[FK506 and kifunensine, new immunomodulators of microbial origin].
Izumi
S
S
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba, Japan.
Okuhara
M
M
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D019703:Calcineurin; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000502:physiology; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology; D016559:Tacrolimus / Q000494:pharmacology* / Q000627:therapeutic use
D000470:Alkaloids; D002148:Calmodulin-Binding Proteins; D007166:Immunosuppressive Agents; C065629:kifunensine; D019703:Calcineurin; D010749:Phosphoprotein Phosphatases; D016559:Tacrolimus